# Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors

> **NCT00178698** · PHASE2 · UNKNOWN · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 36 (estimated)

## Conditions studied

- Neuroendocrine Cancer
- Small Cell Lung Cancer
- Non-Small Cell Lung Cancer
- Gastric Cancer

## Interventions

- **OTHER:** thermochemotherapy
- **DRUG:** Cisplatin, Gemcitabine, Interferon-a
- **OTHER:** thermochemotherapy

## Key facts

- **NCT ID:** NCT00178698
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-07
- **Primary completion:** 2013-06
- **Final completion:** 2014-06
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2011-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00178698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00178698, "Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00178698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*